Search
Vyne Therapeutics Inc
VYNEAdd to Watchlist
28.560USD
0.0000.00%
Market hours （ET）
110.85MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
0.00%
1 Month
0.00%
6 Months
0.00%
Year to Date
0.00%
1 Year
0.00%
Key Figures
--Open
0.000High
0.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.28%Turnover Ratio
28.560Prev. Close
0.000Low
0.00Turnover
LossP/E Static
38.66P/B
0.00%Div Yield TTM
-52.78%ROA
1.96052wk High
0.04Volume Ratio
-39.83MNet Profit
33.35MShares
-0.5012EPS TTM
2.01Beta
-63.16%ROE
0.28152wk Low
1019.65%Amplitude
100.00%Gross Margin
110.85MMarket Cap
10.56Reward/Risk
3.71%Risk Rate
More news coming soon, stay tuned...
Vyne Therapeutics Inc's Score
0.85vs previous score
Forecast7.00
Financial Health6.57
Technical9.90
Valuation Dimensions8.12
Institutional Confidence3.00
Risk Assessment1.71
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q1
Earnings / Forecast
-4.19/-0.18
Revenue / Forecast
86.00K/200.00K
Vyne Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolVYNE
Number of employees13
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Lynx1 Capital Advisors LLC | 4.89% |
| Shay Capital LLC | 4.87% |
| Anson Funds Management LP. | 3.82% |
| Access Industries, Inc. | 3.35% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 17.05% |
| Investment Advisor | 11.66% |
| Corporation | 3.35% |
| Investment Advisor/Hedge Fund | 3.07% |
Related Instruments
+3.79%
+0.54%
-0.25%
+0.78%
+0.87%
+1.55%
+0.01%
-0.17%
+0.77%
+1.35%
+1.42%
-0.52%
+0.14%
+0.34%
-1.18%
-0.66%
+2.33%
+0.97%
-0.98%
+1.35%
FAQs
What is the current price of Vyne Therapeutics Inc (VYNE)?
The current price of Vyne Therapeutics Inc (VYNE) is 28.56.
What is the symbol of Vyne Therapeutics Inc?
The ticker symbol of Vyne Therapeutics Inc is VYNE.
What is the 52-week high of Vyne Therapeutics Inc?
The 52-week high of Vyne Therapeutics Inc is 1.96.
What is the 52-week low of Vyne Therapeutics Inc?
The 52-week low of Vyne Therapeutics Inc is 0.28.
What is the market capitalization of Vyne Therapeutics Inc?
The market capitalization of Vyne Therapeutics Inc is 110.85M.
Is Vyne Therapeutics Inc (VYNE) currently rated as Buy, Hold, or Sell?
According to analysts, Vyne Therapeutics Inc (VYNE) has an overall rating of Buy, with a price target of 71.33.
What is the Earnings Per Share (EPS TTM) of Vyne Therapeutics Inc (VYNE)?
The Earnings Per Share (EPS TTM) of Vyne Therapeutics Inc (VYNE) is -0.50.